Drugs / AD036
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04611750 | Dec 2020 → Jan 2022 | obstructive sleep apnea syndrome | Brigham and Women's Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AD036 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04611750 ↗ |